Curaleaf (OTCMKTS:CURLF) Trading Down 5.5% – Should You Sell?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) traded down 5.5% on Tuesday . The stock traded as low as $3.09 and last traded at $3.1370. 842,105 shares were traded during trading, a decline of 21% from the average session volume of 1,068,583 shares. The stock had previously closed at $3.32.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three equities research analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Performance

The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The stock has a 50 day simple moving average of $2.89 and a two-hundred day simple moving average of $2.66. The company has a market cap of $2.31 billion, a PE ratio of -25.46 and a beta of 1.58.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.17. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The company had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million. Equities analysts predict that Curaleaf Holdings, Inc. will post -0.1 EPS for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.